Routine share withholding; mechanical by default.
Loading…
Traded Dec 5, 2025 · Filed Dec 8, 2025
A board member of Insulet Corporation spent $300K of their very own money to buy Insulet Corporation shares. Their pile of Insulet Corporation shares grew by 27%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$299,884
Shares × reported transaction price
$100K–$500K
+26.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
29 days after results of Nov 6, 2025, 75 days before results of Feb 18, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $304.49 on Dec 5, 2025, 28% above its 52-week low and 14% below its high, after a 6% drop over the previous 30 trading days
52-week range $237.06 (Mar 10, 2025) to $352.82 (Sep 9, 2025), 58% of the way up, from 250 adjusted closes. 30 trading days earlier: $323.46 on Oct 23, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.9% | -0.6% | -1.3% |
| 30 days | -0.5% | +0.9% | -1.4% |
| 90 days | -18.3% | -0.7% | -17.6% |
| 180 days | -48.5% | +8.2% | -56.7% |
Past results only. Not a forecast.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
A board member of Insulet Corporation sold $543K of Insulet Corporation shares. Nobody planned it ahead of time.